Hodgkin Lymphoma - Frontline Therapy
Sort by:
UChicago Medicine
ASH 2024 Treatment Updates in Lymphoma: Practice Changing and Promising Trials
FEATURING
Alexandra Rojek
- 25 views
- March 27, 2025
Stephen M. Ansell
Updates in the Treatment of Frontline and R/R cHL: Clinical Application to Practice
- 6 views
- March 20, 2025
- 1
OncoPharm
Landmark Clinical Trial Insights: SWOG S1826 for Advanced Stage cHL & GCIG INTERLACE Locally Advanced Cervical Cancer
FEATURING
John Bossaer
- 24 views
- February 14, 2025
University of Miami Sylvester Comprehensive Cancer Center
ASH & ISHL 2024 Summary: Key Clinical Questions & Highlights in cHL
FEATURING
Craig Moskowitz
- 175 views
- February 6, 2025
- 6
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: Key Updates in Hodgkin Lymphoma
FEATURING
Molly Gallogly
- 422 views
- February 3, 2025
- 4
ecancer
ASH 2024 Insights: Outcomes of Pembro in Low-Risk Pediatric cHL With Slow Early Response to 1L Chemo
FEATURING
Christine Mauz-Körholz
- 11 views
- January 21, 2025
Penn Medicine Abramson Cancer Center
Advancing Lymphoma Treatment Options: From Bispecific Antibodies to CAR T-Cell Therapy
FEATURING
Michael Cook
- 30 views
- January 6, 2025
UNC Lineberger Comprehensive Cancer Center
2024 Updates in the Management of DLBCL, FL, and HL
FEATURING
Anne Beaven
- 64 views
- November 26, 2024
- 2
Yale Cancer Center
Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL
FEATURING
Tarsheen Sethi
- 239 views
- October 21, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Options for R/R HL: Case Presentation and Discussion
FEATURING
Shahla Shabanova
- 17 views
- October 8, 2024
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 40 views
- October 7, 2024
Yale Cancer Center
Caring for Patients With Lymphoma: Using Guidelines to Improve Quality of Care
FEATURING
Scott Huntington,
Eric Winer
- 85 views
- September 11, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: HL, DLBCL, MCL
FEATURING
Alexandra Rojek
- 148 views
- September 4, 2024
- 3
University of Miami Sylvester Comprehensive Cancer Center
Current Treatment of 1L Hodgkin Lymphoma
FEATURING
Craig Moskowitz
- 597 views
- August 2, 2024
- 2
UChicago Medicine
Are Checkpoint Inhibitors the SOC in Frontline Hodgkin Lymphoma?
FEATURING
Boyu Hu
- 36 views
- July 29, 2024
- 1
UChicago Medicine
Clinical Case Discussions in Hodgkin's Lymphoma
FEATURING
Kaitlin Kelly,
Grace Rivera
- 47 views
- July 29, 2024
UChicago Medicine
Current Standard of Care in Second Line Treatment for Hodgkin Lymphoma
FEATURING
Sarah Rutherford
- 59 views
- July 29, 2024
UChicago Medicine
Identifying Patients Who Benefit the Most From Radiation in Hodgkin Lymphoma
FEATURING
Chelsea Pinnix
- 86 views
- July 29, 2024
UChicago Medicine
Addressing Disparities in Hodgkin Lymphoma: Insights and Ongoing Efforts
FEATURING
Justine Kahn
- 40 views
- July 29, 2024
UChicago Medicine
Managing Toxicity in Pts With cHL Receiving Checkpoint Inhibitors or ADCs
FEATURING
Rebecca Follenweider
- 28 views
- July 22, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Limited Stage HL - Current SOC, Future Directions, and Incorporating BV and Nivo
FEATURING
Steven Park
- 63 views
- July 18, 2024
- 1